Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to 'clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome'.
Scholl S, Popovic M, Rochefordiere A, Girard E, Dureau S, Mandic A, Koprivsek K, Samet N, Craina M, Margan M, Samuels S, Zijlmans H, Kenter G, Hillemanns P, Dema S, Dema A, Malenkovic G, Djuran B, Floquet A, Garbay D, Guyon F, Colombo PE, Fabbro M, Kerr C, Ngo C, Lecuru F, Del Campo ER, Coutant C, Marchal F, Mesgouez-Nebout N, Fourchotte V, Feron JG, Morice P, Deutsch E, Wimberger P, Classe JM, Gleeson N, Leyen HV, Minsat M, Dubot C, Gestraud P, Kereszt A, Nagy I, Balint B, Berns E, Jordanova E, de Saint-Jorre N, Savignoni A, Servant N, Hupe P, de Koning L, Fumoleau P, Rouzier R, Kamal M. Scholl S, et al. Among authors: gleeson n. EBioMedicine. 2020 Jul;57:102875. doi: 10.1016/j.ebiom.2020.102875. Epub 2020 Jul 7. EBioMedicine. 2020. PMID: 32650273 Free PMC article. No abstract available.
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.
Scholl S, Popovic M, de la Rochefordiere A, Girard E, Dureau S, Mandic A, Koprivsek K, Samet N, Craina M, Margan M, Samuels S, Zijlmans H, Kenter G, Hillemanns P, Dema S, Dema A, Malenkovic G, Djuran B, Floquet A, Garbay D, Guyon F, Colombo PE, Fabbro M, Kerr C, Ngo C, Lecuru F, Campo ERD, Coutant C, Marchal F, Mesgouez-Nebout N, Fourchotte V, Feron JG, Morice P, Deutsch E, Wimberger P, Classe JM, Gleeson N, von der Leyen H, Minsat M, Dubot C, Gestraud P, Kereszt A, Nagy I, Balint B, Berns E, Jordanova E, Saint-Jorre N, Savignoni A, Servant N, Hupe P, de Koning L, Fumoleau P, Rouzier R, Kamal M. Scholl S, et al. Among authors: gleeson n. EBioMedicine. 2019 May;43:253-260. doi: 10.1016/j.ebiom.2019.03.069. Epub 2019 Apr 2. EBioMedicine. 2019. PMID: 30952619 Free PMC article.
Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
Kamal M, Lameiras S, Deloger M, Morel A, Vacher S, Lecerf C, Dupain C, Jeannot E, Girard E, Baulande S, Dubot C, Kenter G, Jordanova ES, Berns EMJJ, Bataillon G, Popovic M, Rouzier R, Cacheux W, Le Tourneau C, Nicolas A, Servant N, Scholl SM, Bièche I; RAIDs Consortium. Kamal M, et al. Br J Cancer. 2021 Feb;124(4):777-785. doi: 10.1038/s41416-020-01153-4. Epub 2020 Nov 16. Br J Cancer. 2021. PMID: 33191407 Free PMC article.
Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O, Sheppard B, O' Leary J. Laios A, et al. Among authors: gleeson n. Mol Cancer. 2008 Apr 28;7:35. doi: 10.1186/1476-4598-7-35. Mol Cancer. 2008. PMID: 18442408 Free PMC article.
An integrative model for recurrence in ovarian cancer.
Laios A, O'Toole SA, Flavin R, Martin C, Ring M, Gleeson N, D'Arcy T, McGuinness EP, Sheils O, Sheppard BL, O' Leary JJ. Laios A, et al. Among authors: gleeson n. Mol Cancer. 2008 Jan 22;7:8. doi: 10.1186/1476-4598-7-8. Mol Cancer. 2008. PMID: 18211683 Free PMC article. No abstract available.
A novel serum microRNA panel to discriminate benign from malignant ovarian disease.
Langhe R, Norris L, Saadeh FA, Blackshields G, Varley R, Harrison A, Gleeson N, Spillane C, Martin C, O'Donnell DM, D'Arcy T, O'Leary J, O'Toole S. Langhe R, et al. Among authors: gleeson n. Cancer Lett. 2015 Jan 28;356(2 Pt B):628-36. doi: 10.1016/j.canlet.2014.10.010. Epub 2014 Oct 16. Cancer Lett. 2015. PMID: 25451316
A benign tumor as the apparent trigger for myopathy.
Durcan L, Gleeson N, McKiernan S, Cunnane G. Durcan L, et al. Among authors: gleeson n. J Clin Rheumatol. 2014 Mar;20(2):115-7. doi: 10.1097/RHU.0000000000000083. J Clin Rheumatol. 2014. PMID: 24561420 No abstract available.
163 results